| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YFRNE.2014.01.001 |
| P8608 | Fatcat ID | release_2pbwth4k3je3tcus5t5kiy5obe |
| P932 | PMC publication ID | 4213066 |
| P698 | PubMed publication ID | 24456850 |
| P50 | author | Eric Zorrilla | Q89374001 |
| George Koob | Q5541413 | ||
| Marian L. Logrip | Q42323351 | ||
| P2860 | cites work | Alcohol drinking produces brain region-selective changes in expression of inducible transcription factors | Q73212332 |
| Urocortin 1-containing neurons in the human Edinger-Westphal nucleus | Q80416984 | ||
| Stress-induced and cue-induced craving for alcohol in heavy drinkers: Preliminary evidence of genetic moderation by the OPRM1 and CRH-BP genes | Q24305111 | ||
| Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins | Q24311515 | ||
| Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked? | Q24600288 | ||
| Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse | Q24633835 | ||
| A role for brain stress systems in addiction | Q24649537 | ||
| Early life exposure to a high fat diet promotes long-term changes in dietary preferences and central reward signaling | Q24655015 | ||
| Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism | Q27014879 | ||
| Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide | Q28207724 | ||
| Cloning and structure of the human corticotrophin releasing factor-binding protein gene (CRHBP) | Q28254575 | ||
| Differential sensitivity of the perioculomotor urocortin-containing neurons to ethanol, psychostimulants and stress in mice and rats | Q37157750 | ||
| The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research | Q37164797 | ||
| Stress and alcohol interaction: an update of human research | Q37317789 | ||
| Functional CRH variation increases stress-induced alcohol consumption in primates | Q37321242 | ||
| Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long- but not short-access rats | Q37357463 | ||
| Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval | Q37357483 | ||
| Extended access to cocaine self-administration produces long-lasting prefrontal cortex-dependent working memory impairments. | Q37383580 | ||
| CRF system recruitment mediates dark side of compulsive eating | Q37446510 | ||
| Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking | Q37561918 | ||
| The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF | Q37600348 | ||
| Relevance of both type-1 and type-2 corticotropin releasing factor receptors in stress-induced relapse to cocaine seeking behaviour | Q37917869 | ||
| Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior | Q39299788 | ||
| Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin-releasing factor system | Q39721706 | ||
| Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist | Q40352410 | ||
| Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors | Q40370429 | ||
| Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats | Q40801717 | ||
| Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal | Q40890918 | ||
| Noradrenergic mechanisms in stress and anxiety: II. Clinical studies | Q41045442 | ||
| Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain | Q41075712 | ||
| In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats | Q41665903 | ||
| Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. | Q41680193 | ||
| Role of corticotropin-releasing factor in the median raphe nucleus in yohimbine-induced reinstatement of alcohol seeking in rats | Q41770522 | ||
| Cannabinoid CB1 receptors mediate the effects of corticotropin-releasing factor on the reinstatement of cocaine seeking and expression of cocaine-induced behavioural sensitization | Q42136572 | ||
| Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats | Q42279858 | ||
| Persistent alterations in cognitive function and prefrontal dopamine D2 receptors following extended, but not limited, access to self-administered cocaine | Q42288838 | ||
| Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides | Q28272946 | ||
| Cellular and molecular mechanisms of drug dependence | Q28283898 | ||
| Augmented cocaine seeking in response to stress or CRF delivered into the ventral tegmental area following long-access self-administration is mediated by CRF receptor type 1 but not CRF receptor type 2 | Q28573866 | ||
| Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress | Q28578368 | ||
| Extended access cocaine self-administration differentially activates dorsal raphe and amygdala corticotropin-releasing factor systems in rats | Q28582150 | ||
| Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor | Q28584057 | ||
| An opponent-process theory of motivation: I. Temporal dynamics of affect. | Q29544435 | ||
| Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders | Q29615543 | ||
| The reinstatement model of drug relapse: history, methodology and major findings | Q29616241 | ||
| Drug addiction, dysregulation of reward, and allostasis | Q29616741 | ||
| Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin | Q29617507 | ||
| Corticotropin-releasing factor (CRF) and α 2 adrenergic receptors mediate heroin withdrawal-potentiated startle in rats | Q30431860 | ||
| Anxiolytic-like effects of antisauvagine-30 in mice are not mediated by CRF2 receptors | Q30449644 | ||
| Corticotropin-releasing factor acting on corticotropin-releasing factor receptor type 1 is critical for binge alcohol drinking in mice | Q30458510 | ||
| Stress modulation of drug self-administration: implications for addiction comorbidity with post-traumatic stress disorder | Q30458743 | ||
| Update on corticotropin-releasing factor pharmacotherapy for psychiatric disorders: a revisionist view | Q30459616 | ||
| Prevention of social stress-escalated cocaine self-administration by CRF-R1 antagonist in the rat VTA. | Q30461988 | ||
| Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention | Q30468942 | ||
| Teneurin C-terminal associated peptide-1 blocks the effects of corticotropin-releasing factor on reinstatement of cocaine seeking and on cocaine-induced behavioural sensitization | Q30470848 | ||
| Single-nucleotide polymorphisms in corticotropin releasing hormone receptor 1 gene (CRHR1) are associated with quantitative trait of event-related potential and alcohol dependence | Q30471884 | ||
| Progress in corticotropin-releasing factor-1 antagonist development | Q30475627 | ||
| The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal. | Q30476553 | ||
| Conceptual framework for the etiology of alcoholism: a "kindling"/stress hypothesis | Q30479081 | ||
| Interactions of stress and CRF in ethanol-withdrawal induced anxiety in adolescent and adult rats | Q30479270 | ||
| CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats | Q30485809 | ||
| Disruption of the CRF(2) receptor pathway decreases the somatic expression of opiate withdrawal. | Q30486052 | ||
| Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats | Q30486793 | ||
| A CRF(2) agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats | Q30486940 | ||
| Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs | Q30487401 | ||
| Urocortin 1 microinjection into the mouse lateral septum regulates the acquisition and expression of alcohol consumption | Q30491437 | ||
| Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout | Q30499148 | ||
| ITF expression in mouse brain during acquisition of alcohol self-administration | Q31872440 | ||
| The CRF1 receptor antagonist antalarmin reduces volitional ethanol consumption in isolation-reared fawn-hooded rats | Q33186237 | ||
| Common genetic origins for EEG, alcoholism and anxiety: the role of CRH-BP. | Q33381613 | ||
| Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor. | Q33616639 | ||
| Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study | Q42459669 | ||
| Strain differences in urocortin expression in the Edinger-Westphal nucleus and its relation to alcohol-induced hypothermia | Q42523905 | ||
| Corticotropin-releasing factor mediates the dysphoria-like state associated with alcohol withdrawal in rats | Q42557899 | ||
| Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist | Q42603760 | ||
| Increased anxiety-like behavior and ethanol self-administration in dependent rats: reversal via corticotropin-releasing factor-2 receptor activation | Q42629498 | ||
| Expression of c-Fos in Alko alcohol rats responding for ethanol in an operant paradigm | Q43616553 | ||
| Restricted role of CRF1 receptor for the activity of brainstem catecholaminergic neurons in the negative state of morphine withdrawal | Q43632330 | ||
| Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol | Q43843287 | ||
| Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats | Q43858305 | ||
| Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. | Q43921683 | ||
| Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients | Q43960579 | ||
| The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol. | Q44132553 | ||
| Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. | Q44132559 | ||
| Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor | Q44190199 | ||
| High alcohol/sucrose consumption during dark circadian phase in C57BL/6J mice: involvement of hippocampus, lateral septum and urocortin-positive cells of the Edinger-Westphal nucleus | Q44222956 | ||
| New neuronal networks involved in ethanol reinforcement | Q44327688 | ||
| Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. | Q44332449 | ||
| The Edinger-Westphal-lateral septum urocortin pathway and its relationship to alcohol consumption. | Q44376624 | ||
| Corticotropin releasing factor antagonist, alpha-helical CRF(9-41), reverses nicotine-induced conditioned, but not unconditioned, anxiety | Q44386029 | ||
| Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence | Q44462759 | ||
| Pharmacological blockade of alpha2-adrenoceptors induces reinstatement of cocaine-seeking behavior in squirrel monkeys | Q44761981 | ||
| The anxiogenic drug yohimbine reinstates methamphetamine seeking in a rat model of drug relapse | Q44906813 | ||
| Lesions of the Edinger-Westphal nucleus in C57BL/6J mice disrupt ethanol-induced hypothermia and ethanol consumption | Q45049926 | ||
| Interacting effects of CRHR1 gene and stressful life events on drinking initiation and progression among 19-year-olds. | Q45927860 | ||
| 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors. | Q46085741 | ||
| Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse | Q46125569 | ||
| Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression | Q46137706 | ||
| A prospective study of stress and alcohol craving in heavy drinkers | Q46380466 | ||
| Urocortin 1 distribution in mouse brain is strain-dependent | Q46443027 | ||
| Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the rat. | Q46452934 | ||
| Intermittent access ethanol consumption dysregulates CRF function in the hypothalamus and is attenuated by the CRF-R1 antagonist, CP-376395. | Q46483335 | ||
| Chronic ether stress-induced response of urocortin 1 neurons in the Edinger-Westphal nucleus in the mouse | Q46483553 | ||
| Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. | Q46529874 | ||
| Ataxia and c-Fos expression in mice drinking ethanol in a limited access session | Q46677890 | ||
| Expression of c-Fos in the mouse Edinger-Westphal nucleus following ethanol administration is not secondary to hypothermia or stress | Q46794069 | ||
| Corticotropin releasing factor signaling in the central amygdala is recruited during binge-like ethanol consumption in C57BL/6J mice | Q35839414 | ||
| Ethanol concentration-dependent effects and the role of stress on ethanol drinking in corticotropin-releasing factor type 1 and double type 1 and 2 receptor knockout mice | Q35852967 | ||
| Blockade of CRF1 receptors in the central nucleus of the amygdala attenuates the dysphoria associated with nicotine withdrawal in rats | Q35859810 | ||
| MPZP: a novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist | Q35869282 | ||
| Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats | Q36033490 | ||
| CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats | Q36089365 | ||
| Pharmacogenetic approaches to the treatment of alcohol addiction | Q36126591 | ||
| Recruitment of medial prefrontal cortex neurons during alcohol withdrawal predicts cognitive impairment and excessive alcohol drinking | Q36398095 | ||
| Alcohol in excess: CRF₁ receptors in the rat and mouse VTA and DRN. | Q36456879 | ||
| The urocortin 1 neurocircuit: ethanol-sensitivity and potential involvement in alcohol consumption | Q36502663 | ||
| Effects of the CRF receptor antagonist D-Phe CRF(12-41) and the alpha2-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking behavior in rats | Q36580797 | ||
| Role of a genetic polymorphism in the corticotropin-releasing factor receptor 1 gene in alcohol drinking and seeking behaviors of marchigian sardinian alcohol-preferring rats | Q36759548 | ||
| Impaired object recognition following prolonged withdrawal from extended-access cocaine self-administration | Q36849717 | ||
| CRF1 receptor signaling regulates food and fluid intake in the drinking-in-the-dark model of binge alcohol consumption | Q36854255 | ||
| Behavioral, Biochemical, and Molecular Indices of Stress are Enhanced in Female Versus Male Rats Experiencing Nicotine Withdrawal | Q36854849 | ||
| A key role for corticotropin-releasing factor in alcohol dependence | Q36880698 | ||
| New findings on biological factors predicting addiction relapse vulnerability | Q36908123 | ||
| Effects of CRF1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats | Q36973049 | ||
| Increased perioculomotor urocortin 1 immunoreactivity in genetically selected alcohol preferring rats. | Q33619864 | ||
| Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse | Q33656596 | ||
| Accentuated decrease in social interaction in rats subjected to repeated ethanol withdrawals | Q33832282 | ||
| SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats | Q33856044 | ||
| Corticotropin releasing factor-induced amygdala gamma-aminobutyric Acid release plays a key role in alcohol dependence. | Q33904853 | ||
| Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues | Q33940215 | ||
| Central urocortin 3 administration decreases limited-access ethanol intake in nondependent mice | Q34013102 | ||
| Urocortin-1 within the centrally-projecting Edinger-Westphal nucleus is critical for ethanol preference | Q34064888 | ||
| CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis | Q34082581 | ||
| Ghrelin receptor antagonism decreases alcohol consumption and activation of perioculomotor urocortin-containing neurons | Q34088378 | ||
| Protracted withdrawal from alcohol and drugs of abuse impairs long-term potentiation of intrinsic excitability in the juxtacapsular bed nucleus of the stria terminalis | Q34122457 | ||
| Prairie voles as a novel model of socially facilitated excessive drinking | Q34180005 | ||
| Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. | Q34310825 | ||
| Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats | Q34320180 | ||
| Can induced moods trigger drug-related responses in opiate abuse patients? | Q34342419 | ||
| Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking. | Q34423187 | ||
| Alcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men. | Q34424365 | ||
| Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism | Q34561484 | ||
| Vulnerability to nicotine abstinence-related social anxiety-like behavior: molecular correlates in neuropeptide Y, Y2 receptor and corticotropin releasing factor | Q34570701 | ||
| Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists | Q34588335 | ||
| The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats. | Q34664216 | ||
| H2 haplotype at chromosome 17q21.31 protects against childhood sexual abuse-associated risk for alcohol consumption and dependence | Q34746767 | ||
| Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate | Q34798686 | ||
| Drug wanting: behavioral sensitization and relapse to drug-seeking behavior | Q34858481 | ||
| The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF1 receptors | Q35039457 | ||
| Intermittent access to 20% ethanol induces high ethanol consumption in Long-Evans and Wistar rats | Q35151443 | ||
| Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats: a review | Q35541534 | ||
| Corticotrophin releasing factor (CRF) induced reinstatement of cocaine seeking in male and female rats | Q35577155 | ||
| Pharmacological blockade of corticotropin-releasing hormone receptor 1 (CRH1R) reduces voluntary consumption of high alcohol concentrations in non-dependent Wistar rats | Q35624173 | ||
| CRF and CRF receptors: role in stress responsivity and other behaviors | Q35639182 | ||
| Nicotine self-administration and reinstatement of nicotine-seeking in male and female rats | Q35673450 | ||
| Brain-specific inactivation of the Crhr1 gene inhibits post-dependent and stress-induced alcohol intake, but does not affect relapse-like drinking | Q35760218 | ||
| The therapeutic potential of CRF1 antagonists for anxiety | Q35814456 | ||
| The dark side of food addiction | Q35832522 | ||
| Lesions of the Edinger-Westphal nucleus alter food and water consumption | Q46814074 | ||
| Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats | Q46865593 | ||
| The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. | Q47892402 | ||
| CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats | Q47964905 | ||
| Differences in the urocortin 1 system between long-sleep and short-sleep mice | Q48117685 | ||
| Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala crhr1 expression following a history of dependence | Q48129172 | ||
| Reinstatement of cocaine seeking in rats by the pharmacological stressors, corticotropin-releasing factor and yohimbine: role for D1/5 dopamine receptors | Q48153940 | ||
| Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain | Q48201356 | ||
| Stress-induced relapse to cocaine seeking: roles for the CRF(2) receptor and CRF-binding protein in the ventral tegmental area of the rat. | Q48201478 | ||
| Region-specific down-regulation of Crhr1 gene expression in alcohol-preferring msP rats following ad lib access to alcohol | Q48218243 | ||
| 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. | Q48250731 | ||
| The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal | Q48274036 | ||
| Disruption of the CRF/CRF1 receptor stress system exacerbates the somatic signs of opiate withdrawal. | Q48274815 | ||
| Possible neural substrates of beer-craving in rats | Q48384747 | ||
| Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats. | Q48432702 | ||
| Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. | Q48495677 | ||
| Increases of CRF in the amygdala are responsible for reinstatement of methamphetamine-seeking behavior induced by footshock. | Q48709875 | ||
| Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. | Q48757178 | ||
| Relapse research and the Reasons for Drinking Questionnaire: a factor analysis of Marlatt's relapse taxonomy. | Q48776970 | ||
| Replication and extension of Marlatt's taxonomy of relapse precipitants: overview of procedures and results. The Relapse Research Group. | Q48782992 | ||
| Antagonism of CRF(2) receptors produces anxiolytic behavior in animal models of anxiety. | Q48862386 | ||
| CRF2 receptor-deficiency eliminates opiate withdrawal distress without impairing stress coping. | Q48879979 | ||
| Studies on duration of a late recovery period after chronic abuse of ethanol. A cross-sectional study of biochemical and psychiatric indicators. | Q48882384 | ||
| Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor. | Q48908477 | ||
| Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. | Q48918115 | ||
| Clinical conditions in alcoholics during long-term abstinence: a descriptive, longitudinal treatment study. | Q49043135 | ||
| Effects of a stressor and corticotrophin releasing factor on ethanol deprivation-induced ethanol intake and anxiety-like behavior in alcohol-preferring P rats. | Q50625670 | ||
| Subtype-selective corticotropin-releasing factor receptor agonists exert contrasting, but not opposite, effects on anxiety-related behavior in rats. | Q50888047 | ||
| Remission and resurgence of anxiety-like behavior across protracted withdrawal stages in ethanol-dependent rats. | Q50889796 | ||
| Gender in relation to relapse crisis situations, coping, and outcome among treated alcoholics. | Q50907758 | ||
| Psychological stress, drug-related cues and cocaine craving. | Q51074066 | ||
| Corticotropin releasing factor produces behavioural activation in rats. | Q51249282 | ||
| Alcohol withdrawal symptoms and drinking behavior. | Q51285959 | ||
| Interaction between CRHR1 gene and stressful life events predicts adolescent heavy alcohol use. | Q51902104 | ||
| Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. | Q51920093 | ||
| The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. | Q51975321 | ||
| Association of Low-Voltage Alpha EEG With a Subtype of Alcohol Use Disorders | Q60628088 | ||
| Voluntary ethanol intake in rats following exposure to ethanol on various schedules | Q69513977 | ||
| Relapse by alcohol abusers | Q69898723 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurobiology | Q2728012 |
| P304 | page(s) | 234-244 | |
| P577 | publication date | 2014-01-20 | |
| P1433 | published in | Frontiers in Neuroendocrinology | Q15716620 |
| P1476 | title | Corticotropin releasing factor: a key role in the neurobiology of addiction | |
| P478 | volume | 35 |
| Q41108544 | A Quantitative Analysis of the Distribution of CRH Neurons in Whole Mouse Brain |
| Q55302175 | A medial prefrontal cortex-nucleus acumens corticotropin-releasing factor circuitry for neuropathic pain-increased susceptibility to opioid reward. |
| Q38710343 | Abstinence from prolonged ethanol exposure affects plasma corticosterone, glucocorticoid receptor signaling and stress-related behaviors. |
| Q58699476 | Acupuncture on the Stress-Related Drug Relapse to Seeking |
| Q30399803 | Addictions Neuroclinical Assessment: A reverse translational approach |
| Q36421071 | Alcohol Use Disorder Increases the Risk of Irritable Bowel Disease: A Nationwide Retrospective Cohort Study |
| Q38907897 | Alterations in the corticotropin-releasing hormone (CRH) neurocircuitry: Insights into post stroke functional impairments |
| Q37118753 | Amphetamine Withdrawal Differentially Increases the Expression of Organic Cation Transporter 3 and Serotonin Transporter in Limbic Brain Regions. |
| Q35966724 | Amphetamine-induced sensitization and reward uncertainty similarly enhance incentive salience for conditioned cues |
| Q28069782 | An Update on CRF Mechanisms Underlying Alcohol Use Disorders and Dependence |
| Q58788199 | Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework |
| Q58770001 | Aqueous Extract of Semen Exerts Anxiolytic Effects during Nicotine Withdrawal via Improvement of Amygdaloid CRF/CRF1R Signaling |
| Q90686593 | Biological intersection of sex, age, and environment in the corticotropin releasing factor (CRF) system and alcohol |
| Q92510690 | Brain and Cognition for Addiction Medicine: From Prevention to Recovery Neural Substrates for Treatment of Psychostimulant-Induced Cognitive Deficits |
| Q92189687 | Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future |
| Q87492031 | CRF as the key component of stress response systems |
| Q35092156 | Chronic intermittent ethanol exposure produces persistent anxiety in adolescent and adult rats |
| Q26752316 | Consumption of Substances of Abuse during Pregnancy Increases Consumption in Offspring: Possible Underlying Mechanisms |
| Q26864379 | Corticotrophin-releasing factor 1 activation in the central amygdale and visceral hyperalgesia |
| Q92083041 | Corticotropin Releasing Factor Type 1 and 2 Receptor Signaling in the Medial Prefrontal Cortex Modulates Binge-Like Ethanol Consumption in C57BL/6J Mice |
| Q47610214 | Corticotropin-Releasing Factor From Rodents to Primates: Translational Hope Expresses Itself, Pun Intended |
| Q38950447 | Corticotropin-Releasing Factor Receptors and Their Interacting Proteins: Functional Consequences |
| Q36305137 | Diversity of Reporter Expression Patterns in Transgenic Mouse Lines Targeting Corticotropin-Releasing Hormone-Expressing Neurons |
| Q43101490 | Dopamine D1 and corticotrophin-releasing hormone type-2α receptors assemble into functionally interacting complexes in living cells |
| Q56000529 | Dramatic enhancement of the detection limits of bioassays via ultrafast deposition of polydopamine |
| Q46584440 | Effects of adolescent alcohol exposure on stress-induced reward deficits, brain CRF, monoamines and glutamate in adult rats. |
| Q27022504 | Emergence of sex differences in the development of substance use and abuse during adolescence |
| Q37397620 | Emerging targets for addiction neuropharmacology: From mechanisms to therapeutics |
| Q38542455 | Endocrine-Autonomic Linkages |
| Q39436094 | Endocrinology and the brain: corticotropin-releasing hormone signaling |
| Q47774751 | Escalated cocaine "binges" in rats: enduring effects of social defeat stress or intra-VTA CRF. |
| Q38365273 | Ethanol and corticotropin releasing factor receptor modulation of central amygdala neurocircuitry: An update and future directions |
| Q52315997 | Evaluation of Alcohol Preference and Drinking in msP Rats Bearing a Crhr1 Promoter Polymorphism. |
| Q47381036 | Fibroblast growth factor 2 alters the oxytocin receptor in a developmental model of anxiety-like behavior in male rat pups |
| Q26768236 | Fischer 344 and Lewis Rat Strains as a Model of Genetic Vulnerability to Drug Addiction |
| Q34578173 | Food addiction: an evolving nonlinear science |
| Q42374856 | G2B Reviews: stress at the intersection of anxiety, addiction and eating disorders |
| Q28566355 | Genoarchitecture of the extended amygdala in zebra finch, and expression of FoxP2 in cell corridors of different genetic profile |
| Q58585931 | Genome-Wide Association Study Meta-Analysis of the Alcohol Use Disorders Identification Test (AUDIT) in Two Population-Based Cohorts |
| Q91781423 | Impulsivity Derived From the Dark Side: Neurocircuits That Contribute to Negative Urgency |
| Q35081542 | Increased alcohol consumption in urocortin 3 knockout mice is unaffected by chronic inflammatory pain |
| Q60301810 | Indomethacin blocks the increased conditioned rewarding effects of cocaine induced by repeated social defeat |
| Q39255467 | Influence of stress associated with chronic alcohol exposure on drinking |
| Q40125735 | Involvement of metabotropic glutamate receptor 5 in the inhibition of methamphetamine-associated contextual memory after prolonged extinction training |
| Q34521105 | Keep off the grass? Cannabis, cognition and addiction |
| Q34435527 | Knockdown of CRF1 receptors in the ventral tegmental area attenuates cue- and acute food deprivation stress-induced cocaine seeking in mice. |
| Q39633339 | Maladaptive choices by defeated rats: link between rapid approach to social threat and escalated cocaine self-administration |
| Q47903195 | Methamphetamine Induces TET1- and TET3-Dependent DNA Hydroxymethylation of Crh and Avp Genes in the Rat Nucleus Accumbens |
| Q38904980 | Molecular mechanisms underlying alcohol-drinking behaviours |
| Q57170466 | Negative consequences of early-life adversity on substance use as mediated by corticotropin-releasing factor modulation of serotonin activity |
| Q35132317 | Neuroanatomical and functional characterization of CRF neurons of the amygdala using a novel transgenic mouse model. |
| Q38616747 | Neuropeptide Y in Alcohol Addiction and Affective Disorders |
| Q52315306 | Neuropharmacology of compulsive eating. |
| Q33806745 | PAC1 receptor (ADCYAP1R1) genotype and problematic alcohol use in a sample of young women |
| Q92860111 | Persistent activation of central amygdala CRF neurons helps drive the immediate fear extinction deficit |
| Q90417346 | Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review |
| Q90734129 | Pituitary Adenylate Cyclase-Activating Peptide (PACAP) Signaling and the Dark Side of Addiction |
| Q102063579 | Pituitary adenylate cyclase-activating polypeptide (PACAP) modulates dependence-induced alcohol drinking and anxiety-like behavior in male rats |
| Q92268146 | Pleiotropic actions of allopregnanolone underlie therapeutic benefits in stress-related disease |
| Q36852840 | Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation |
| Q39142990 | Rat animal models for screening medications to treat alcohol use disorders. |
| Q38944155 | Region-specific roles of the corticotropin-releasing factor-urocortin system in stress. |
| Q34882307 | Role of Corticotropin-releasing Factor Signaling in Stress-related Alterations of Colonic Motility and Hyperalgesia |
| Q43067978 | Schisandra chinensis and Rhodiola rosea exert an anti-stress effect on the HPA axis and reduce hypothalamic c-Fos expression in rats subjected to repeated stress |
| Q55032383 | Serotonergic Neuroplasticity in Alcohol Addiction. |
| Q48067919 | Sex differences in the ontogeny of CRF receptors during adolescent development in the dorsal raphe nucleus and ventral tegmental area |
| Q39171620 | Sex-dependent mental illnesses and mitochondria |
| Q39129525 | Social defeat in adolescent mice increases vulnerability to alcohol consumption. |
| Q59137249 | Social defeat stress and escalation of cocaine and alcohol consumption: Focus on CRF |
| Q43065495 | Social stress-escalated intermittent alcohol drinking: modulation by CRF-R1 in the ventral tegmental area and accumbal dopamine in mice |
| Q33444193 | Some of the people, some of the time: field evidence for associations and dissociations between stress and drug use. |
| Q26798016 | Stress exposure, food intake and emotional state |
| Q58868594 | Stress increases GABAergic neurotransmission in CRF neurons of the central amygdala and bed nucleus stria terminalis |
| Q41189421 | Substance use disorders as a cause and consequence of childhood abuse. Basic research, therapy and prevention in the BMBF-funded CANSAS-Network |
| Q40835344 | Suppression of piriform cortex activity in rat by corticotropin-releasing factor 1 and serotonin 2A/C receptors |
| Q28551732 | The Anorexigenic Peptide Neuromedin U (NMU) Attenuates Amphetamine-Induced Locomotor Stimulation, Accumbal Dopamine Release and Expression of Conditioned Place Preference in Mice |
| Q30387331 | The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle |
| Q47416625 | The Dark Side of Addiction: The Horsley Gantt to Joseph Brady Connection |
| Q27310605 | The Dorsal Agranular Insular Cortex Regulates the Cued Reinstatement of Cocaine-Seeking, but not Food-Seeking, Behavior in Rats |
| Q50644115 | The HPA axis and ethanol: a synthesis of mathematical modelling and experimental observations. |
| Q90107822 | The Negative Affect of Protracted Opioid Abstinence: Progress and Perspectives From Rodent Models |
| Q34510753 | The Nociceptin Receptor as an Emerging Molecular Target for Cocaine Addiction |
| Q36236950 | The affective dimension of pain as a risk factor for drug and alcohol addiction. |
| Q35696171 | The role of the gut-brain axis in alcohol use disorders |
| Q90633626 | Withdrawal from Brief Repeated Alcohol Treatment in Adolescent and Adult Male and Female Rats |
Search more.